fructose-6-phosphate has been researched along with Diabetes Mellitus, Type 2 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Hale, C; Han, J; Kurzeja, RJ; Michelsen, K; St Jean, DJ; Vazir, M; Wahl, RC | 1 |
Balasubramanyan, N; Bitragunta, S; Natarajan, A; Sugumar, S | 1 |
Fujiwara, T; Hagisawa, Y; Izumi, M; Ohsumi, J; Okuno, A; Takahashi, K; Yoshida, T | 1 |
Bie, JB; Li, ZM; Song, HR; Xu, BL | 1 |
Campos, G; Durante, P; Gómez, ME; Raleigh, X; Ryder, E | 1 |
Barzilai, N; Chen, W; Hawkins, M; Hu, M; Liu, R; Rossetti, L | 1 |
1 review(s) available for fructose-6-phosphate and Diabetes Mellitus, Type 2
Article | Year |
---|---|
[Recent advance in the discovery of allosteric inhibitors binding to the AMP site of fructose-1,6-bisphosphatase].
Topics: Adenosine Monophosphate; Allosteric Site; Animals; Binding Sites; Blood Glucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fructose-Bisphosphatase; Fructosediphosphates; Fructosephosphates; Humans | 2011 |
5 other study(ies) available for fructose-6-phosphate and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Discovery of Small-Molecule Glucokinase Regulatory Protein Modulators That Restore Glucokinase Activity.
Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphate; Allosteric Regulation; Animals; Blood Glucose; Calorimetry; Diabetes Mellitus, Type 2; Drug Discovery; Fluorescence; Fluorometry; Fructosephosphates; Glucokinase; Hepatocytes; Hexosephosphates; Homeostasis; Humans; Hypoglycemia; Inhibitory Concentration 50; Luminescence; Protein Binding; Protein Conformation; Protein Interaction Mapping; Rats; Surface Plasmon Resonance | 2014 |
Molecular docking studies of (4Z, 12Z)-cyclopentadeca-4, 12-dienone from Grewia hirsuta with some targets related to type 2 diabetes.
Topics: Aldehyde Reductase; Cyclopentanes; Diabetes Mellitus, Type 2; Enzymes; Fructosephosphates; Grewia; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Phytotherapy; Plant Extracts; Plant Leaves; PPAR gamma; Transcription Factors | 2015 |
CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats.
Topics: Alanine; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Fructose-Bisphosphatase; Fructosediphosphates; Fructosephosphates; Gluconeogenesis; Hyperglycemia; Liver; Male; Organophosphonates; Organophosphorus Compounds; Rats; Rats, Wistar | 2008 |
Isozyme analysis of human polymorphonuclear leukocyte phosphofructokinase from insulin resistant individuals.
Topics: Adenosine Triphosphate; Case-Control Studies; Citrates; Citric Acid; Diabetes Mellitus, Type 2; Enzyme Activation; Enzyme Inhibitors; Fructosediphosphates; Fructosephosphates; Humans; Insulin Resistance; Isoenzymes; Kinetics; Neutrophils; Obesity; Phosphofructokinase-1; Substrate Specificity | 1996 |
Role of the glucosamine pathway in fat-induced insulin resistance.
Topics: Animals; Diabetes Mellitus, Type 2; Fatty Acids; Fructosephosphates; Glucosamine; Glucose; Glucose-6-Phosphate; Glycogen; Glycolysis; Insulin; Insulin Resistance; Male; Muscle, Skeletal; Phosphorylation; Rats; Rats, Sprague-Dawley; Uridine | 1997 |